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Machine learning algorithms can be trained to estimate age from brain structural MRI. The
difference between an individual’s predicted and chronological age, predicted age difference
(PAD), is a phenotype of relevance to aging and brain disease. Here, we present a new deep
learning approach to predict brain age from a T1-weighted MRI. The method was trained on a
dataset of healthy Icelanders and tested on two datasets, IXI and UK Biobank, utilizing
transfer learning to improve accuracy on new sites. A genome-wide association study
(GWAS) of PAD in the UK Biobank data (discovery set: N ¼ 12378, replication set:
N ¼ 4456) yielded two sequence variants, rs1452628-T (β ¼ 0:08, P ¼ 1:15´ 109) and
rs2435204-G (β ¼ 0:102, P ¼ 9:73´ 1012). The former is near KCNK2 and correlates with
reduced sulcal width, whereas the latter correlates with reduced white matter surface area
and tags a well-known inversion at 17q21.31 (H2).
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Ageing has a significant structural impact on the brain thatcorrelates with decreased mental and physical fitness1 andincreased risk of neurodegenerative diseases such as
Alzheimer’s disease2 and Parkinson’s disease3. Recent publica-
tions, have demonstrated that MRIs can be used to predict
chronological age with reasonably good accuracy1,4,5. Such
predictions provide an estimate of biological brain age in inde-
pendent samples. The traditional way to perform brain age pre-
diction is to extract features from brain MRIs followed by
classification or regression analysis. This includes extracting
principal components4, cortical thickness and surface curvature6,
volume of gray matter (GM), white matter (WM), and cere-
brospinal fluid (CSF)7, and constructing a similarity matrix8. The
drawback of using feature extraction methods is loss of infor-
mation since the features are likely not designed explicitly for
extracting information relevant to brain age. Recently, deep
learning (DL) methods have garnered much interest9. These
methods learn features that are important without a priori bias or
hypothesis. Convolutional neural networks (CNNs)10 are deep
learning techniques that are especially powerful for image pro-
cessing and computer vision. Previously, they have been applied
to brain age prediction11,12. Notably, Cole et al.12 implemented a
3D CNN trained on T1-weighted MRIs to predict brain age and
achieved promising results.
PAD (the difference between predicted brain age and chron-
ological age) estimates the deviation from healthy ageing. Studies
have shown that positive PAD correlates with measures of
reduced mental and physical fitness; including weaker grip
strength, poorer lung function, slower walking speed, lower fluid
intelligence, higher allostatic load, and increased mortality risk1.
In addition, positive PAD has been shown to associate with
cognitive impairments5,8,13,14, diabetes15, traumatic brain inju-
ries8, schizophrenia16,17, and chronic pain18. On the other hand, a
negative PAD associates with higher educational attainment19,
increased physical activity19, and meditation20. Moreover, PAD
has been demonstrated to be heritable12,21 and to have a poly-
genic overlap with brain disorders such as schizophrenia, bipolar
disorder, multiple sclerosis, and Alzheimer’s disease21. Further-
more, the high degree of genetic correlation found among psy-
chiatric and some neurological disorders suggests that current
diagnostic boundaries do not necessarily reflect underlying biol-
ogy22. Hence, defining a novel phenotype capturing global age-
related changes in brain structure could, via variants in the
sequence of the genome that associate with these changes, provide
novel biological insights.
Here we present a new brain age prediction method (Fig. 1)
that uses a 3D CNN trained on MRIs to predict brain age. The
input data are a T1-weighted image registered to Montréal
Neurological Institute (MNI) space and data derived from the T1-
weighted image, i.e., a Jacobian map, and gray and white matter
segmented images (Fig. 1). The input data also include infor-
mation about the subject’s sex and the type of MRI scanner. The
output of the network is the predicted brain age.
As mentioned above, Cole et al.12 trained a 3D CNN to per-
form brain age prediction. Our network is different in four key
ways. (1) We use a significantly different architecture. While their
architecture resembles a standard VGGNet architecture23 our
architecture uses the recent ResNet design24. One of the draw-
backs of the VGG architecture is that the vanishing gradient
problem limits the potential depth of the network. In contrast, the
ResNet architecture has no such depth limits. ResNets also have
smoother loss surfaces25, which in turn helps speeding up con-
vergence. (2) We add inputs to the final CNN layer to factor in
information about sex and scanner. (3) Our technique is the first
to use deformation information encoded in Jacobian maps to
predict brain age. (4) As we have mentioned, our method
combines predictions from multiple CNNs by either averaging
predictions or by training a data blender.
In experiments, we compare our proposed method to a few
brain age prediction methods based on feature extraction and
machine learning. We also demonstrate that transfer learning is
useful for adapting a CNN trained to predict brain age on one site
to a new site while retaining predictive accuracy. And we look at
how the PAD calculated with our method is affected by random
weight initialization and retraining. We then check for associa-
tions between PAD and performance on neuropsychological
tests. Finally, we perform genetic analysis on PAD using UK
Biobank data, resulting in identification of associations with five
sequence variants for which we provide detailed phenotypic
characterizations.
Results
Combining CNN outputs improves prediction accuracy. Our
brain age prediction method was developed using images from
structural brain MRIs for 1264 healthy Icelanders. To overcome
problems caused by training a DL method on such a small dataset
we use multiple images of the same individuals and utilize a data
augmentation strategy. We start off by training the method
independently on the four previously mentioned image types
(Table 1A). The CNN that predicts the test set with the least error
is the CNN trained on T1-weighted images followed by the CNN
trained on WM segmented images (Supplementary Figs. 4 and 5
show scatter plots of the CNN test set predictions against
chronological age).
Having four predictions from four different data sources opens
up the possibility of combining the predictions. The most
straightforward way of fusing the forecasts is by using a majority
voting scheme, e.g., by averaging the predictions made by the four
CNNs. Another way to combine forecasts is to implement a data
blender, for example, by implementing a linear regression model
trained to predict brain age from the four CNN brain age
predictions. This technique attempts to find the best linear
combination of the four brain age predictions so in theory it
should be guaranteed to be at least as good as the best predicting
CNN method. To demonstrate this, we tried combining CNN
brain age predictions using majority voting and linear regression
data blending (Table 1B). Comparing the test set results of
Table 1B to the results in Table 1A, we see that combining
predictions results in lower test error than achieved by the CNN
trained on T1-weighted images.
It is not straightforward to compare the accuracy of our
method to previous brain age prediction methods, because they
are evaluated on other datasets. However, to establish a baseline
for the CNN-based techniques, we investigated methods based on
feature extraction such as surface-based morphometry (SBM)26,
voxel-based morphometry (VBM)27, and similarity matrices.
Machine learning regression methods were trained on these three
types of features separately. For each feature type, we trained
eight different types of regression methods. The list of methods
we tried is far from exhaustive, instead these methods were
chosen to represent commonly used and relatively simple to tune
regression methods. In addition, we considered methods such as
relevance vector regression (RVR)28 and Gaussian process
regression (GPR)29 which have previously been successfully used
to predict brain age4,8. Table 1C shows the prediction results for
the regression models with the lowest test error for each feature
type (the Methods section and Supplementary Table 1 include
more information and results for the regression methods trained
on these features). In addition, Table 1C shows results for
combining the best predictions for SBM, VBM and similarity
matrix features using the same methods used to combine the
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CNN predictions. Similarly to the CNNs, the combined
predictions have lower test MAE than any of the methods
limited to single feature types. However, if we compare the results
in Table 1B and C we see that the predictions made with
combined CNN outputs are more accurate than any of those
based on the feature extraction methods.
Testing the CNN on other datasets. Next, we examine how the
method performs if we predict brain age of images from other
datasets. To do so, we evaluate it on the IXI and UK Biobank30
datasets and combine predictions using majority voting. We use
this combination method rather than data blending because it has
similar accuracy to linear regression blender with the added
benefit that it is unnecessary to train an extra linear model on the
predictions. We observe that the initial prediction error of the
method is high (Table 2). The problem is that there can be subtle
differences between data from different scanning sites which will
cause a model trained on one site to fail when predicting on the
other site. There are multiple reasons for this. The MRI scanner
type and parameters between sites can be different, which can
cause differences between resolution, contrast and noise levels.
Also, the distribution of age can be different between sites, for
example, it is problematic if the new site has a wider age range
than the training set.
We hypothesize that a CNN that is already proficient at
predicting brain age at one site only needs a small adjustment to
adapt to data from a new site. A transfer learning strategy
achieves this: First, we freeze the model weights of the
convolutional layers so that only the fully connected layers are
trainable. Second, the CNN is re-trained on a portion of the data











Fig. 1 Illustration of the proposed method and input data. a A flowchart showing a high-level overview of the proposed brain age prediction system.
b Examples of image types generated by the preprocessing step. From left to right: a registered T1-weighted slice, a Jacobian map slice, a GM segmented
slice, and a WM segmented slice.
Table 1 Chronological age prediction accuracy for the considered methods.
Type Method Val MAE Val R2 Test MAE Test R2 No. I
(A) T1-weighted CNN 3.996 0.810 4.006 0.829 1815
Jacobian CNN 4.801 0.710 4.804 0.758 1815
Gray matter CNN 4.766 0.721 4.641 0.776 1815
White matter CNN 4.676 0.735 4.189 0.812 1815
(B) MV (T1 and JM) CNN 4.102 0.803 3.919 0.841 1815
MV (GM and WM) CNN 4.172 0.790 3.674 0.849 1815
MV (T1, JM, and GM) CNN 3.964 0.813 3.838 0.847 1815
MV (T1, JM, GM, and WM) CNN 3.845 0.849 3.584 0.849 1815
LRB (T1, JM, GM, and WM) CNN 3.581 0.847 3.388 0.872 1815
(C) SBM RR 5.268 0.689 5.176 0.697 1320
VBM GPR 4.278 0.781 4.317 0.766 1794
SM RR 4.898 0.722 4.937 0.728 1815
MV (SBM, VBM, and SM) GPR/RR 4.008 0.808 3.940 0.761 1246
LRB (SBM, VBM, and SM) GPR/RR 3.906 0.812 3.849 0.766 1246
(A) The best results are shown in bold. (B) The training/validation/test split is the same as for (A).
(C) The cross validation was performed using 10-fold cross validation. The SBM feature training/test split was 1056/264, the VBM feature training/test split was 1438/356, and the SM feature training/
test split was 1469/346
(A) The performance of the CNNs that were trained using T1-weighted images, Jacobian maps, GM and WM segmented images. Training set (N ¼ 1171), validation set (N ¼ 298), and test set
(N ¼ 346). (B) The performance when combining CNN predictions. (C) The results of the best methods trained on SBM, VBM and similarity matrix features
CV cross validation, GM gray matter, I images, JM Jacobian map, LRB linear regression blender, MV majority voting, MAE mean absolute error, RR ridge regression, SM similarity matrix, SBM surface-
based morphometry, val validation, VBM voxel-based morphometry, WM white matter
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now fewer parameters to train, which means we can use less data
and training will be faster. We carry out the transfer learning
strategy by retraining the majority voting CNN on 440 images
from the IXI dataset.
The re-trained CNN is validated on 104 images from the IXI
dataset left out during training (validation set) and tested on
12395 images from the UK Biobank dataset (test set). Table 2
shows that the prediction accuracy is increased significantly by
doing so. In addition, the test set predictions before and after
transfer learning are shown on a scatter plot against chronological
age (Supplementary Fig. 6). Surprisingly the accuracy of
predictions for the UK Biobank site improve even though the
CNN was not explicitly trained on it. This is intriguing and is
perhaps explained by the fact that the IXI set includes a wider age
range than the Icelandic set and includes 3T MRI images unlike
the Icelandic set.
In subsequent sections, the CNNs trained with transfer
learning on the IXI sample will be used in downstream analysis
of the UK Biobank sample. While it is likely that transfer learning
on a small subset of the UK Biobank sample will lower the UK
Biobank test MAE, we refrained from doing this because we want
to use as many subjects as possible in the downstream analysis
and because of the limited age range in the UK Biobank sample
(all subjects are in the age range 45–80 years). Training on such a
limited age range would severely bias the model towards
predicting ages inside this range. To get around this, it is
necessary to train the model on a sample with a wider age range.
This is why we use the CNNs trained on the IXI sample, which
includes subjects in the age range 20–86 years, in the downstream
analysis.
Effect of random CNN weight initialization on PAD. We know
that because CNNs start out in random initial states, and because
they have highly non-convex loss functions25, it is possible that
two randomly initialized instances of our brain age prediction
method will converge to two distinct local minima. These states
could in theory both predict age equally well but have uncorre-
lated PAD values. Here we face a potential problem, because in
the absence of a ground truth for the PAD there is no way to tell
if either one of these PAD predictions is accurate. This sort of
unreliable CNN behavior would be problematic for any down-
stream analysis that utilizes the brain age prediction, because any
conclusions made about the PAD would depend on the initi-
alization of the CNN. In light of this, it would be reassuring if we
could demonstrate that our method generally converges to similar
PAD predictions after training.
To test this, four additional randomly initialized instances of
our brain age prediction method are trained and the agreement
between their PADs is examined. This procedure entails repeating
these three main steps four times: (1) Train four CNNs on the
Icelandic dataset on the four previously mentioned image types.
(2) Freeze convolutions layers and train the CNNs on the IXI
dataset (transfer learning step). (3) Predict brain age in the UK
Biobank dataset using CNNs, combine the predictions with
majority voting and calculate PAD values.
After repeating these steps, we get four instances of the brain
age prediction method that predict brain age of the 12395 subjects
in the UK Biobank with mean absolute error (MAE) equal to 4.6,
5.5, 5.4, and 4.9 years, respectively. The reason why the error is
higher here compared with the original results is that we did not
reinitialize and retrain the CNNs in cases were the optimization
got stuck in a poor local minimum or a saddle point.
Nevertheless, if we look at the agreement of the original and
the four new PADs we find that the intraclass correlation (ICC) is
estimated to be equal to 0.86 (95% confidence interval [CI]=
[0.855, 0.863]). This indicates that the UK Biobank PAD
calculated using our method stays rather consistent between the
five different training runs and is relatively robust to random
weight initialization.
Associations between PAD and performance on neu-
ropsychological tests. As mentioned above, previous studies have
linked high PAD to cognitive impairment5,8,13,14. In light of this,
we are interested in looking at if PAD associates with perfor-
mance on neuropsychological tests. Specifically, performance on
tests administered by the UK Biobank that are designed to
measure: fluid intelligence, numeric memory, visual memory,
prospective memory, simple processing speed, complex proces-
sing speed, visual attention, and verbal fluency. To estimate PAD
in the UK Biobank, we train four CNNs on the Icelandic set, then
the IXI set using transfer learning, and combine their predictions
using majority voting. We did not find evidence of association
between PAD and performance on the fluid intelligence, numeric
memory, pairs matching, and prospective memory tests (Sup-
plementary Table 2 includes these results). However, we see from
Table 3 that PAD is associated with worse performance on the
digit substitution test (DSST), trail making tests (TMTs), and the
reaction time test (a more detailed description of the tests can be
found in Supplementary Notes 1–7). As expected, these results
indicate that PAD is in fact associated with cognitive impairment.
Genome-wide association study. PAD has previously been
shown to be heritable12,21, however, to our knowledge no
sequence variants conferring risk of or protecting against PAD
have been identified. In order to look for such variants, we ran a
genome wide association scan (GWAS) in the UK Biobank
sample on PAD (same PAD as from the section Testing the CNN
on other datasets) using BOLT-LMM31. This scan yields two
sequence variants, rs2435204-G and rs1452628-T (Fig. 2 and
Table 4A) (Supplementary Figs. 8 and 9 show locus zoom plots
for the two genome-wide significant variants). In addition, given
that sequence variants known to associate with brain structure are
likely to be enriched for variants that associate with PAD. We
decided to test a smaller set of 331 brain structure variants for
association with PAD. This yielded associations with three
additional variants (Table 4B). For more information, the ‘Sta-
tistical methods’ section contains information about how the
brain structure variants were identified.
The high number of tests conducted in GWAS combined
with the general small effect size of common markers greatly
Table 2 UK Biobank and IXI prediction performance with and without transfer learning.
IXI UK Biobank
TL Used Val MAE Val R2 Val set size Test MAE Test R2 Test set size
No 6.420 0.778 104 8.494 −0.630 12395
Yes 4.149 0.907 104 3.631 0.614 12395
The best results are shown in bold
S subjects, TL transfer learning, val validation
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increases the risk of a false postives32. To protect against potential
confound effects we adjusted for potential nuisance variables,
such as age, gender, total intracranial volume, principal
components from genetic ancestry analysis, head motion,
genotyping array, and imaging center. In addition, we removed
individuals of non-white British ancestry and one subject from
each related pair of individuals (the Statistical Methods section
provides more information about the exact adjustment proce-
dure). And then to thoroughly vet each hit we took two steps.
(1) We performed a replication test on held out data. (2) Checked
if the reported variants associate with other phenotypes related to
brain ageing.
(1) The five reported sequence variants also associated with
PAD in a replication set of 4456 subjects (Table 4 [C, D]). Four
other variants which came up in the discovery stage were omitted
because they did not replicate. (2) The identified sequence
variants also associate with brain structure likely to be affected by
brain ageing. Associations between these sequence variants and
SBM/VBM brain structure phenotypes and correlation between
PAD and the brain structure phenotypes are shown in
Supplementary Tables 4 and 5. Supplementary Table 4 shows
that both PAD and rs1452628-T associate with lower CSF
throughout the cerebral cortex which is consistent with reduced
cortical sulcal openings. On the other hand, rs2435204-G
associates with lower total white matter surface area, and reduced
area in a number of cortical brain regions (Supplementary
Table 5). Although it was known a priori that the other three
sequence variants would associate with structural brain
Table 4 Sequence variants associated with PAD estimated using BOLT-LMM.
rs Number (GRCh38) Position (min/maj) Allele MAF (%) Effect 95% CI P Value
(A) rs2435204 chr17:45910839 G/A 26.6 0.11 (0.08, 0.14) 1.4e−12
rs1452628 chr1:214966544 T/A 36.2 −0.08 (−0.10, −0.05) 2.3e−09
(B) rs2790099 chr6:45475612 C/T 36.0 −0.06 (−0.09, −0.03) 8.9e−06
rs6437412 chr3:194747684 C/T 28.2 −0.06 (−0.09, −0.04) 6.8e−06
rs2184968 chr6:126439848 C/T 46.0 0.05 (0.03, 0.08) 7.5e−05
(C) rs2435204 chr17:45910839 G/A 26.6 0.08 (0.03, 0.13) 1.5e−03
rs1452628 chr1:214966544 T/A 36.2 −0.07 (−0.12, −0.03) 8.8e−04
(D) rs2790099 chr6:45475612 C/T 36.0 −0.07 (−0.11, −0.02) 2.9e−03
rs6437412 chr3:194747684 C/T 28.2 −0.05 (−0.09, 0.00) 4.9e−02
rs2184968 chr6:126439848 C/T 46.0 0.06 (0.02, 0.10) 2.9e−03
(A, B) Association between sequence variants and PAD for 12378 subjects in discovery set. (A) Genome-wide significant sequence variants. (B) Sequence variants associated with structural MRI brain
phenotypes that also associate with PAD. (C, D) Association between sequence variants and PAD for 4456 subjects from the replication set. (C) Genome-wide significant sequence variants. (D)
Sequence variants associated with structural MRI brain phenotypes that also associate with PAD. Note that the reported effect sizes are for PAD normalized to unit variance. Before normalization the
standard deviation of PAD was ~4 years. Thus the associated lowering of the protective allele of rs1452628 is approximately −0.32 years
CI confidence interval, MAF minor allele frequency
Table 3 Pearson’s r correlation between PAD and performance on neuropsychological tests.
Neuropsychological test PAD correlation 95% CI P Value No. subjects
DSST −0.080 (−0.104, −0.054) 4.3e−11 6849
TMT B 0.076 (0.051, 0.103) 3.1e−09 6076
TMT A 0.053 (0.027, 0.078) 3.8e−05 6076
TMT B - A 0.050 (0.024, 0.075) 1.3e−04 5918
Reaction time 0.030 (0.012, 0.047) 7.9e−04 12387
Negative DSST, positive TMT, and positive reaction time indicate worse performance
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Fig. 2 Manhattan plot of the GWAS results for the UK Biobank data. The horizontal line denotes the P value threshold for genome-wide significant effect.
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phenotypes, the specific structural brain phenotypes that associate
with these variants are listed in Supplementary Tables 6–8.
Running LD score regression33 on the GWAS results, we
estimated the SNP-heritability for PAD to be h2snp ¼ 0:264 (95%
CI= [0.178, 0.350]). In addition, the intercept of the LD score
regression model is equal to 0.991 (95% CI= [0.979, 1.003]),
which indicates that the model did not find any evidence of
confounding effects in the PAD GWAS results. This h2snp estimate
is close to the one previously estimated by Kaufmann et al.21
(h2snp ¼ 0:1828 [SE¼ 0:02]). And predictably our h2snp is lower
than the narrow-sense heritability estimate of PAD estimated by
Cole et al.12 (h2 ¼ 0:66 [SE¼ 0:09]) using a twin study sample.
Discussion
Here, we have presented a novel deep learning approach, using
residual convolutional neural networks to predict brain age from
a T1-weighted MRI, a Jacobian map, and gray and white
matter segmented images, to study the discrepancy between age-
related structural brain changes and chronological age. The MRI
based deep learning system was shown to predict brain age from
T1-weighted MRI data with a MAE ¼ 3:39 and R2 ¼ 0:87 on
test data. Comparing our approach to other machine learning
methods trained on surface-based morphometry, voxel-based
morphometry, and similarity matrix features, we showed that our
approach predicts brain age more accurately. We showed
that transfer learning can be used to efficiently increase prediction
accuracy for new sites. The PAD calculated using this method was
shown to be relatively robust to random weight initialization
and retraining, a result that indicates that the PAD estimated
using our method can be used as a reliable phenotype in the
study of brain ageing, as well as in the study of specific
disorders of the brain. We also proposed that PAD could be an
informative phenotype for genetic association studies, and indeed,
our association analysis of PAD in a discovery set of 12378 sub-
jects and replication set of 4456 subjects yielded five sequence
variants.
The sequence variant with the strongest association,
rs2435204-G, tags the H2 (inverted) form of the 17q21.31
inversion polymorphism34. This inversion spans ~1Mb and
includes 10 genes, including MAPT, a gene that encodes the tau
protein which has been implicated in various dementias35. In
addition, micro-deletions within the inversion are known to cause
intellectual disability36. The H1 inversion haplotype has been
associated with increased risk of Parkinson’s disease, male-
pattern baldness, and several other phenotypes, whereas H2 has
been associated with a number of phenotypes including neuro-
ticism37, fibromyalgia18, lower educational attainment, increased
fecundity38, and smaller intracranial volume (ICV)39 (Note that
PAD is adjusted for ICV, thus the observed effect on PAD is not
caused by ICV). Due to the extensive linkage disequilibrium (LD)
the 17q21.31 inversion region, reported markers for various
associations in the region often differ between studies. For
example, the most recent GWAS meta-analysis of Parkinson’s
disease reports an association with rs17649553-T, that is fixated
on and highly correlated with the H2-tagging rs2435204-G
(r2 ¼ 0:82, D0 ¼ 1), with OR ¼ 0:78 (95% CI ¼ ½0:76; 0:80), P=
1:26 ´ 1068 (their meta-analysis was carried out with a fixed-
effects model based on inverse-variance weighting)40.
rs2435204-G also associates with brain structure phenotypes.
Supplementary Table 5, shows that both PAD and rs2435204-G
associate with increased thickness and decreased area in cortical
brain regions. Interestingly, this pattern of increased thickness
and decreased area has previously been associated with neuroti-
cism41. Thus, lifestyle or phenotypes associated with a high
neuroticism score, including anxiety, worry, fear, anger, frustra-
tion, depressed mood, and loneliness may associate with PAD.
The other genome-wide significant sequence variant, rs1452628-
T, is located close to KCNK2 (also known as TREK1), which belongs
to the two-pore domain potassium channel family and is mainly
expressed in the brain42. In mice, KCNK2 has been implicated in
neuroinflammation43, cerebral ischemia44, and blood-brain barrier
dysfunction45. rs1452628-T correlates with SNPs that have pre-
viously been associated with cortical sulcal opening and GM
thickness, rs6667184 (r2 ¼ 0:68), and rs864736 (r2 ¼ 0:49)46.
In addition, we identified three sequence variants associated
with PAD by restricting the analysis to SNPs known a priori to
associate with structural phenotypes. (1) rs2790099-C is located
in an intron of RUNX2, a gene that encodes the RUNX2 protein
which is essential for osteoblastic differentiation and skeletal
morphogenesis and has been shown to play several roles in cell
cycle regulation47. Supplementary Fig. 7 shows that rs2790099-C
is a possible cis-eQTL of RUNX2 and it is most expressed in the
basal ganglia (caudate and putamen). This lines up with the a
priori brain structure GWAS that shows that rs2790099-C has
genome-wide significant associations with white matter volume of
regions in the basal ganglia (putamen and pallidum) (Supple-
mentary Table 6). (2) rs6437412-C is an intron variant of
LINC01968 that associates with increased cortical CSF (Supple-
mentary Table 7). (3) rs2184968-C is located in an intron of
CENPW, a gene that has previously been associated with traits,
such as, height48, cognitive performance49, and male-pattern
baldness50. Our analysis shows that rs2184968-C is associated
with increased CSF in subcortical regions and increased size of
the fourth ventricle (Supplementary Table 8).
Confound effects are a problem for big imaging studies due to
the huge number of imaging artifacts that can potentially influence
both imaging and non-imaging variables of interest32. Some of the
confound effects we have tried to control for are effects due to age,
sex, head size, population structure, and scanner type. Head motion
is another potentially problematic confound effect, because it causes
reduction of estimated gray matter volume and thickness in MRI
images similar to what we expect to see due to ageing51. While head
motion is not important in the evaluation of our method (see Cole
et al.12), it is potentially a problematic confound for GWAS analysis
because certain clinical groups associate more with scanner motion.
Elliott et al.52 suggest to use fMRI-derived head motion estimates to
correct for confound effects due to head motion when running
GWAS analysis on brain structure phenotypes. We adjusted PAD
for head motion as they suggest, however, this correction only had a
small effect on our results. Other potential confounds that we
looked at were sample relatedness (the first 40 principal from
components genetic ancestry analysis), genotyping array, and the
assessment center where neuropsychological testing was performed.
As with head motion, adjusting for these variables did not affect our
results.
From our analysis we see that PAD associates with worse
performance on neuropsychological tests, specifically poor per-
formance on DSST, TMT, and the reaction time tests (Table 3).
Interestingly, both the DSST and the reaction time test are
designed to measure cognitive processing speed. The TMT is
designed to asses visual attention. However, psychomotor speed is
a factor in successful TMT performance53. Furthermore, a decline
in processing speed along with impairment of reasoning, mem-
ory, and executive function are well documented to occur in age-
associated cognitive decline54. As such, these results are in line
with other studies that link high PAD to cognitive impair-
ment5,8,13,14. We note, that the association between PAD and
TMT is consistent with the previous finding of Cole et al.8.
However, the large dataset used here gives more conclusive
results. Supporting this, we additionally find that schizophrenia, a
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brain disorder characterized by complex patterns of cognitive
impairment, correlates with positive PAD (greater brain ageing
than chronological age) and (Supplementary Table 3).
In conclusion, we have presented a new method for predicting
brain age using cutting-edge machine learning techniques. Our
deep learning method produces a single measure (PAD) from raw
MRI data that captures complex underlying correlated changes in
MRI and can be used to study various traits and diseases, and in
particular for genetic discovery. Using such a method represents
one potential way for overcoming challenges with high dimen-
sional data and multiple testing that plagues MRI research.
Applying our method to large genomic datasets such as the UK
Biobank has enabled us to identify novel associations between
sequence variants and brain ageing. The variants identified are
common SNPs with small effects on PAD (Table 4) accounting
for only a fraction of the trait variance. However, these first
findings provide a foothold, and further research into these loci as
well as additional GWAS studies have potential to shed light on
the biological underpinnings of the ageing brain and its con-
nection to various diseases and disorders.
Methods
Datasets. The proposed method was evaluated on T1-weighted MR images from
three independent datasets: an Icelandic dataset, the UK Biobank dataset, and the
IXI dataset. DeCODE genetics provided the Icelandic MR data, consisting of scans
from 1264 healthy subjects aged between 18 and 75 years. This dataset includes
1815 scans in total, since some subjects have several scans. The Icelandic data were
acquired using two different scanners, a 1.5T Phillips Achieva scanner, and a 1.5T
Siemens Magnetom Aera scanner. Scans were imaged using a T1-weighted gradient
echo sequence (Philips Achieva: repetition time (TR)= 8.6 ms, echo time (TE)=
4.0 ms, flip angle (FA)= 8°, 170 slices, slice thickness= 1.2 mm, acquisition
matrix= 192 ´ 192, FOV= 240 ´ 240 mm; Siemens Aera: repetition time (TR) =
2400 ms, echo time (TE)= 3.54 ms, flip angle (FA)= 8°, 160 slices, slice thickness
= 1.2 mm, acquisition matrix= 192 ´ 192, FOV= 240 ´ 240 mm). Any serious
neurological disorders were prescreened and removed. In addition, we removed
from the training and holdout sets subjects diagnosed with neurodevelopmental
and mental disorders such as autism, bipolar disorder, intellectual disability, or
schizophrenia, and subjects with any copy number variations previously associated
with neurodevelopmental or psychiatric disorders.
The UK Biobank dataset consists of T1-weighted MR images of 15040 healthy
subjects aged between 46 and 79 years old. The data were all collected using a 3T
Siemens Skyra scanner. It is well-known that the presence of undetected population
structure can lead to both false positive results and failure to detect genuine
associations in genetic association studies55, in an effort to combat this our analysis
was constrained to 12378 individuals of white British ancestry. An additional
release of MRI images by UK Biobank was added to a replication set. This set
contains 6888 subjects (thereof 4456 subjects of white British ancestry) aged
between 47 and 80 years old. The images in this set were collected using the same
protocol as the previous UK Biobank set.
The IXI dataset consists of T1-weighted MR images of 544 healthy subjects and
is freely available online. The subjects age at imaging was between 20 and 86 years
old. The IXI data were collected from three different sites. The Hammersmith
Hospital using a Philips 3T system, Guy’s Hospital using a Philips 1.5T system and
the Institute of Psychiatry using a GE 1.5T system. Histograms of the age
distribution of the three datasets mentioned are shown in Supplementary Figs. 1–3.
Preprocessing. Preprocessing was carried out using the computational anatomy
toolbox (CAT12)56. First, the input data were inhomogeneity corrected. Then the
skull and other non-brain elements were removed. Finally, the images were
registered into the standard MNI space using the deformable registration algorithm
DARTEL57. For further information, refer to the CAT12 manual58.
There are three types of images that the preprocessing step generates. The first
is an MNI-registered image. Second, a Jacobian map which is a by-product of the
deformable registration. Last, a gray matter and white matter soft segmented image.
All of the image types mentioned above have voxel size 1.5 mm3 and voxel
resolution 121 × 145 × 121.
CNN architecture. The CNN architecture we developed is based on the residual
architecture24 (Fig. 3). It was implemented using Keras with TensorFlow as
backend59 and consists of five residual blocks, each followed by a max pooling layer
of stride 2 × 2 × 2 and kernel size 3 × 3 × 3, and one fully connected block. The
convolutional part of the CNN reduces the input image from size 121 × 145 × 121
to 128 feature maps of size 4 × 5 × 4. The fully connected part reduces these feature
maps down to an age prediction.
The residual block, displayed in Fig. 4, consists of a combination of layers which
are repeated twice inside the residual blocks. This combination is composed of a 3D
convolutional layer with stride 1 × 1 × 1 and kernel size 3 × 3 × 3, a batch re-
normalization layer60, and an ELU activation function61. The defining element of
the residual block is the skip connection which adds the signal feeding into the
residual block to the output of a layer close to the end of the block. The number of
feature maps in block number n was chosen by the rule 2nþ2.
The fully connected block, depicted in Fig. 5, is a multilayer perceptron (MLP)62
with one hidden layer. The input layer has 128´ 4 ´ 5 ´ 4 ¼ 10240 neurons, the
hidden layer (FC 1) has 256 neurons that use an ELU activation function, and the
output layer has a single neuron. Following the hidden layer, a dropout63 layer with
keep rate equal to 0.8 is employed. The output layer (FC 2) has no activation
function which means that it performs a linear regression on the hidden layer
features. To account for factors such as scanner type and sex that can affect the
estimated brain age of an individual we include them as inputs in the linear
regression by concatenating them with the hidden features of the MLP.
The mean absolute error was used as the loss function and the CNN was
optimized using Adam64 with parameters: learning rate ¼ 0:001, decay= 106,
β1 ¼ 0:9, β2 ¼ 0:999, and batch size¼ 4. The He initialization strategy65 was used
to initialize the weights, and each trainable node in the CNN was regularized with
l2 weight decay
66, with λ ¼ 5 ´ 105. Early stopping67 with model
checkpointing was used, i.e., if the validation error did not improve in 100 epochs
the training was stopped and the weights with the lowest validation error selected.
Furthermore, to reduce the risk of overfitting, data augmentation68 was used to
generate new training instances by applying a coordinate transformation to a
random subset of the training data, consisting of a combined 3D rotation and a 3D


































Fig. 5 A flowchart showing the components of the proposed fully
connected block. Fully connected layer one (FC1), concatenation layer















































































Fig. 3 A flowchart showing the components of the proposed CNN

































Fig. 4 A flowchart showing the components of the proposed residual block.
Batch re-normalization (BRN), convolutional layer (Conv).
NATURE COMMUNICATIONS | https://doi.org/10.1038/s41467-019-13163-9 ARTICLE
NATURE COMMUNICATIONS |         (2019) 10:5409 | https://doi.org/10.1038/s41467-019-13163-9 |www.nature.com/naturecommunications 7
and the translation distance, for each direction, was selected between −10 and 10
voxels with equal probability.
Our CNN implementation uses about ~8 GB of memory and the training time
using an Intel Xeon Gold 6130 Processor CPU with 32GB of RAM and an NVIDIA
Tesla V100 16GB GPU was about 2 days.
SBM, VBM, and similarity matrix brain age prediction. The SBM features were
generated using FreeSurfer’s recon-all algorithm69 and the VBM features were
generated using the CAT12 toolbox (the specific names of the SBM and VBM
features are listed in Supplementary Data 1). The similarity matrix was constructed
by taking the inner product between the combined gray and white matter seg-
mented images of each subject. The SBM and VBM features were adjusted for
intracranial volume, sex and scanner type. The features were then zero centered
and normalized to unit variance. The regression methods that were tested were,
linear regression70, lasso71, ridge regression72, elastic net73, random forest regres-
sion74, support vector regression75, relevance vector regression28, and Gaussian
process regression29. A grid search was used to find the tuning parameters cor-
responding to the lowest cross-validation error for the methods mentioned. The
regression models were implemented using scikit-learn76, except relevance vector
machines, which used scikit-rvm.
In addition, we tested combining predictions made by models trained on these
three feature types. We decided to pick predictions for the method with the lowest
CV MAE for each feature type. Specifically, these regression methods were GPR
with a Matérn kernel for both the SBM and VBM, and ridge regression for the
similarity matrix features. The methods were picked by CV MAE instead of test
MAE to prevent data leakage. Since the SBM and VBM features were not available
for every image in the Icelandic dataset, we first calculated the average brain age
prediction for each subject, before inner joining the predictions by subject into a
single data frame. This resulted in a combined data frame with 1246 rows and three
columns containing brain age predictions for the three regression methods. Since
training these regression models is faster than training the CNNs, we were able to
combine them using 10-fold cross-validation predictions. Thus, the linear
regression blender can train on predictions from the whole training set, instead of
being limited to the 298 images in the validation set, as is the case for the CNN
prediction combination.
Statistical methods. To assess the accuracy of the machine learning methods we
performed simple training and validation splits, and selected a suitable model by
evaluating the validation MAE. The subjects from the Icelandic sample were split
between these three sets, and if a subject had multiple images, the images were all
put in the same set. The data were divided into 64% training set (Ns ¼ 809,
Ni ¼ 1171), 16% validation set (Ns ¼ 202, Ni ¼ 298), and 20% test set (Ns ¼ 253,
Ni ¼ 346), were Ns is the number of subjects and Ni is the number of images.
When evaluating the machine learning models the MAE and R2 score for the
images in the validation and test set is calculated.
To assess the transfer learning performance, the IXI dataset was split into 80%
training set (N ¼ 440), 20% validation set (N ¼ 104) and the whole UK Biobank
dataset was used as a test set (N ¼ 12395). As before, we evaluate accuracy by
calculating the MAE and R2 score on the validation and test set.
In order to test the reliability of PAD, the intraclass correlation was calculated
with ICCbare from the ICC R package. The 95% confidence interval was estimated
using bootstrapping with 2000 sampling iterations.
The Pearson correlation coefficient was calculated in order to test for
association between PAD and performance on neuropsychological tests. Before
performing the association test we first removed individuals of non-white British
ancestry and subjects from related pairs. We then adjusted the PAD for age at
imaging visit, age2, sex, age ´ sex, age2 ´ sex, total intracranial volume, the first 40
principal components from genetic ancestry analysis, head motion, genotyping
array, imaging center, and assessment center where neuropsychological tests were
conducted. The adjustments was performed using linear regression. Adjustment for
variables such as genotyping array are probably not necessary for testing for
association between PAD and performance on neuropsychological tests. However,
we included them to keep the adjusted PAD similar to the one we perform the
GWAS on. Nine correlation tests were performed, so a Bonferroni adjusted
significance level αB2 ¼ 0:05=9  0:00556 was used. We estimated the 95%
confidence interval using bootstrapping with 2000 sampling iterations.
We performed a GWAS on PAD using BOLT-LMM31 to find associated
sequence variants. For the genetic analysis we used version 3 of the imputed genetic
dataset released by UK Biobank in July 201777. The UK Biobank genetic data were
assayed using two very similar genotyping arrays (95% of marker content is
shared). Roughly 10% of the subjects were genotyped using applied Biosystems UK
BiLEVE Axiom Array by Affymetrix and the rest using the closely related Applied
Biosystems UK Biobank Axiom Array77. Variants with imputation quality score
below 0.3, and minor allele frequency below 0.1% were filtered out, which left ~20
million variants to be considered for GWAS. Before performing GWAS, we
removed individuals of non-white British ancestry and subjects from related pairs.
We then adjusted the PAD for age at imaging visit, age2, sex, age ´ sex, age2 ´ sex,
total intracranial volume, the first 40 principal components from genetic ancestry
analysis, head motion, genotyping array, and imaging center using linear
regression. The adjusted PAD was then normalized with an inverse normal
transformation. After normalization the linear regression adjustments were
reapplied. Sequence variants associated with PAD are only reported if they reach
genome-wide significance. If two genome-wide significant variants are in LD
(r2 > 0:1) we report the variant with the lower P-value.
In addition, we tested for association between PAD and sequence variants
known to associate with structural brain phenotypes. These variants were found by
performing GWAS separately on 305 SBM phenotypes generated with recon-all by
using the Freesurfer 6.0 software69 and 540 VBM phenotypes generated by using
CAT1256. All genome-wide significant markers were then aggregated into a single
list. In cases where variants were in LD (r2 > 0:5), only the variant with the lower
P-value was selected. The final list included 331 variants, to account for testing test
variants for the second time a Bonferroni adjusted significance level αB3 ¼ 0:052331 
7:5 ´ 105 was used for the PAD association test.
To reduce the risk of false positive sequence variant associations we additionally
checked for association in a replication set of 4456 subjects. To pass this test the
association between the variants under consideration and PAD need to show
evidence of statistical significance (αR < 0:05).
Heritability analysis. To estimate SNP-heritability (h2snp) we ran LD score regres-
sion33 on the PAD GWAS summary statistics. We used the ldsc command line tool
and followed standard procedure when running it. To train the LD score regression
model, we used precomputed European 1000 Genomes phase 3 LD Scores, and
filtered out rare variants with MAF < 0.01 and imputation quality score < 0.9. The
slope of the trained regression model times the number of SNPs and divided by the
sample size is an estimate of h2snp
33. In addition, the intercept of the model minus one
is a measure of confounding bias in the test statistics due to confounding effect, such
as cryptic relatedness and population stratification33.
eQTL analysis. To investigate if any of the variants are expression quantitative
trait loci (eQTLs) we used the GTEx database (GTEx Analysis Release V7 [dbGaP
Accession phs000424.v7.p2])78. Our eQTL analysis was carried out by logging onto
https://gtexportal.org, typing in the corresponding rs number of identified variants,
and checking if they have any associated eQTLs. However, identifying whether a
variant is truly causal in both GWAS and eQTL is challenging because of the
uncertainty caused by LD79. Therefore, we only report variants as eQTLs of genes if
they are close to being the most significant eQTL of that specific gene.
Ethical regulations. The Icelandic participants in this study were recruited by
deCODE genetics to study the cognitive and neurological effects of rare variants
previously associated with schizophrenia and autism spectrum disorder. The UK
Biobank oversaw the recruitment of subjects of British nationality. Approval for the
aforementioned schizophrenia study was obtained from the National Bioethics
Committee of Iceland and the Icelandic Data Protection Authority. Written
informed consent was obtained from all participants or their guardians before
blood samples or phenotypic data were obtained. All sample identifiers were
encrypted in accordance with the regulations of the Icelandic Data Protection
Authority. Information about ethics oversight in the UK Biobank can be found at
https://www.ukbiobank.ac.uk/ethics/.
Reporting summary. Further information on research design is available in
the Nature Research Reporting Summary linked to this article.
Code availability
Any custom code or software used to implement the brain age prediction method
detailed in this paper will be made available upon request.
Data availability
The genetic and phenotype datasets generated by UK Biobank used in this study are
available via the UK Biobank data access process (see http://www.ukbiobank.ac.uk/
register-apply/). Detailed information about the genetic data and MRI data available in
UK Biobank is listed here: http://www.ukbiobank.ac.uk/scientists-3/genetic-data/, https://
www.fmrib.ox.ac.uk/ukbiobank/. The Icelandic data used in this publication are not
publicly available due to information, contained within them, that could compromise
research participant privacy. The authors declare that the data supporting the findings of
this study are available within the article, its supplementary information, and upon
request.
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